Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress

Molecular and Cellular Biochemistry

Volumn 387, Issue 1-2, 2014, Pages 261-270

  Lu, Weidong ^a   Fu, Zhongxue ^a   Wang, Hao ^a   Feng, Jihong ^a   Wei, Jinlai ^a   Guo, Jinbao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Colorectal cancer; Overexpression; Oxidative stress; Prdx2; Survival

Indexed keywords

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIREDOXINS; UP-REGULATION;

EID: 84893845890     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1891-4     Document Type: Article

References (30)

1. Jemal A, Bray F, Center Melissa M et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Hall A, Karplus PA, Poole LB (2009) Typical 2-Cys peroxiredoxins- structures, mechanisms and functions. FEBS J 276(9):2469-2477
3. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P (2008) Redox regulation of cell survival. Antioxid Redox Signal 10(8):1343-1374
4. Ruckenstuhl C, Büttner S, Carmona-Gutierrez D et al (2009) The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer. PLoS ONE 4(2):e4592
5. Lee KW, Lee DJ, Lee JY et al (2011) Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair. J Biol Chem 286(10):8394-8404
6. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279 (Pubitemid 37487159)
7. Park SA, Choi KS, Bang JH et al (2000) Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J Neurochem 75:946-953 (Pubitemid 30660482)
8. Zhiyu W, Yue C, Neng W et al (2012) Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol Ther 13(3):138-147
9. Valdman A, Haggarth L, Cheng L et al (2009) Expression of redox pathway enzymes in human prostatic tissue. Anal Quant Cytol Histol 31(6):367-374
10. Lomnytska MI, Becker S, Hellman K et al (2010) Diagnostic protein marker patterns in squamous cervical cancer. Proteomics Clin Appl 4(1):17-31
11. Järvelä S, Rantala I, Rodriguez A et al (2010) Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors. BMC Cancer 10:104
12. Shau H, Kim A (1994) Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. Biochem Biophys Res Commun 199:83-88
13. Netto LE, Kowaltowski AJ, Castilho RF et al (2002) Thiol enzymes protecting mitochondria against oxidative damage. Methods Enzymol 348:260-270 (Pubitemid 41103116)
14. Zhang P, Liu B, Kang SW et al (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272:30615-30618 (Pubitemid 27527491)
15. Park SH, Chung YM, Lee YS et al (2000) Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin Cancer Res 6:4915-4920
16. Yoo YD, Chung YM, Park JK et al (2002) Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death. Exp Mol Med 34:273-277 (Pubitemid 35221663)
17. Kim H, Lee TH, Park ES et al (2000) Role of peroxideroxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275:18266-18270 (Pubitemid 30414779)
18. Zhao Fang, Wang Qinghua (2012) The protective effect of peroxiredoxin II on oxidative stress induced apoptosis in pancreatic β-cells. Cell Biosci 2(1):22
19. Lim MJ, Chae HZ, Rhee SG et al (1998) The type II peroxiredoxin gene family of the mouse: molecular structure, expression and evolution. Gene 216:197-205 (Pubitemid 28389118)
20. Noh DY, Ahn SJ, Lee RA et al (2001) Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 21:2085-2090
21. Wu XY, Fu ZX, Wang XH (2010) Peroxiredoxins in colorectal neoplasms. Histol Histopathol 25:1297-1303
22. Kang SW, Chae HZ, Seo MS et al (1998) Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 273:6297-6302 (Pubitemid 28144719)
23. Qu D, Rashidian J, Mount MP et al (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55:37-52 (Pubitemid 46990825)
24. Yang S, Luo A, Hao X et al (2011) Peroxiredoxin 2 inhibits granulosa cell apoptosis during follicle atresia through the NFKB pathway in mice. Biol Reprod 84(6):1182-1189
25. Brunelle JK, Letai A (2009) Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122:437-441
26. Fulda S (2010) Exploiting mitochondrial apoptosis for the treatment of cancer. Mitochondrion 10:598-603
27. Yang C, Liu HZ, Fu ZX (2012) Effects of PEG-liposomal oxaliplatin on apoptosis, and expression of cyclin A and cyclin D1 in colorectal cancer cells. Oncol Rep 28(3):1006-1012
28. Luo X, Budihardjo I, Zou H et al (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490 (Pubitemid 28391864)
29. Walters J, Pop C, Scott FL et al (2009) A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J 424:335-345
30. Janicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357-9360 (Pubitemid 28183012)